Registered medicines undergo extensive review to assess their quality, safety, and effectiveness before they can be supplied to patients
The GIP receptor is very widely expressed throughout all neuroendocrine tumors, so it may be a matter of suggesting to patients that perhaps they could be on a GLP-1 agent, but they cannot be on a GLP-1/GIP agent
Evolving CMS Policy on Anti-Obesity Medications Historically, Medicare Part D excluded coverage for weight loss drugs under a statutory provision allowing Medicaid programs to do the same
PubMed, Yang, Xiaohong, et al
Sidenote: We discussed about GLP-1 in depth in this podcast
N-Acetyl-L-Cysteine (NAC) is an antioxidant that promotes intracellular glutathione at the cellular level